XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
CALGARY, Alberta, Oct. 17, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX...
CALGARY, Alberta, Oct. 17, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX...
Retrospective Study demonstrates clinical efficacy and statistical support for tissue processed via BioREtain to care for treatment-resistant chronic wounds Study...
Both Acute Respiratory Diseases and Infections and Encounter for Examination Fell Out of the National Top Five Telehealth Diagnostic Categories...
Record Gross and Net Revenue: Generated $9.6 million Gross Revenue and $8.5 million Net Revenue in Q3 2024, establishing new...
Partnership Will Enhance Support for Biopharmaceutical Companies in Developing Cell and Gene Therapies and mRNA-Based Treatments NASHVILLE, Tenn. and CONROE,...
Leading veterinary experts to present educational programs featuring Zomedica product applications at the Fetch dvm360 Veterinary Conference ANN ARBOR, MI...
SHELTON, CT / ACCESSWIRE / October 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader...
DENVER, Oct. 15, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary...
Calgary, Alberta--(Newsfile Corp. - October 11, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to...
Week Begins with In-Depth Discussions on Life Science Trends and Celebrates Innovative Products that Have Made a Significant Impact on...
Westat is honored to continue its partnership with AHRQ to conduct MEPS-HC, which is integral to AHRQ's mission to produce...
UTRECHT, The Netherlands, Oct. 10, 2024 /PRNewswire/ -- Vitestro, the innovator behind the world's first autonomous blood drawing device, is...
The workflow management system market size is projected to reach US$ 60.02 billion by 2031 from US$ 10.23 billion in...
News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA...
– Company has received a No Objection Letter from Health Canada in response to submission of its Phase 1 Clinical...
NEW YORK, Oct. 9, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The Global Infrared Thermometers Market...
Exclusive exhibit will enable attendees to experience simulated patient scenarios and determine treatment and therapy actionsTechnology behind the virtual hospital...
TORONTO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a...
Data from three separate clinical trials documents the strong ability of the AI-Immunology™ platform to select clinically relevant vaccine targets...
The Company recently announced the positive topline results from the Phase 2b study with istaroxime in acute heart failure patients...